Charles Philip Steuber, MD
Dr. Phil Steuber completed his internship, residency and fellowship at Texas Children’s Hospital, followed by becoming an attending physician in the Texas Children’s Cancer Center. As the Director of the Education Division, Dr. Steuber has mentored nearly 180 pediatric hematology/oncology fellows and has treated thousands of patients with cancer and blood disorders. Dr. Steuber continues to make a tremendous impact on a daily basis and is well-loved by his colleagues and patients alike. In January 2018, Dr. Steuber celebrated his 50th anniversary as a physician at Texas Children's Hospital.
Dr. Phil Steuber's primary interest is in the development of improved anticancer therapies for childhood leukemia through the use of randomized therapeutic trials. He particularly is interested in the pilot studies necessary to establish and recommend new agents and combinations for use in children with newly diagnosed leukemia. Dr. Steuber has participated in the design and piloting of cooperative group phase III studies for both acute lymphoid and myeloid leukemia. He is currently involved in study committees for a clinical trial for children with standard risk acute lymphoid leukemia and for therapies for infants with leukemia.
He is board certified by the American Board of Pediatrics in general pediatrics and pediatric hematology/oncology.
Clinical Special Interests
Hematologic problems in pediatrics
Improved anticancer therapies for childhood leukemia
Randomized therapeutic trials
Master Clinician Award for Excellence in Patient Care, Baylor College of Medicine, 2019
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.